Clicks Group (CLS) Deutsche Bank ADR Virtual Investor Conference summary
Event summary combining transcript, slides, and related documents.
Deutsche Bank ADR Virtual Investor Conference summary
24 Nov, 2025Strategic roadmap and retail initiatives
Focus on leveraging investments through store modernization, rejuvenation, and targeted category enhancements, especially in beauty, health, and baby segments.
Expansion of Baby stores and online offerings to capture loyal, high-value customers and create a halo effect.
Continued investment in e-commerce and omnichannel capabilities, with strong omni growth supporting further investment.
Implementation of Project LEAP (pharmacy software) and Beyonder (assortment optimization) to improve service, forecasting, and reduce lost sales.
Retail store footprint surpassed 950, with guidance to open 45–55 new stores and pharmacies in the current financial year, aiming for the upper end of guidance.
Differentiation, loyalty, and future growth
Private label and exclusive brands now contribute over 31% of sales, supporting income margins amid regulated pharmacy pricing.
ClubCard loyalty program exceeds 12 million members, contributing over 80% of total sales and driving higher pharmacy footfall.
Launch of UniCare, a large 24/7 pharmacy format, broadening catchment area and reinforcing health and wellness leadership.
Website and app refresh led to 800,000 new app downloads and 37% growth in app shopping.
Central compounding and expanded distribution center initiatives aim to boost efficiency and customer engagement.
Customer value, convenience, and enablers
Emphasis on value, personalization, and convenience, with over 51% of the population within 5 km of a store.
Differentiation through private label, exclusive brands, and strategic enablers like centralized supply chain and IT platforms.
Latest events from Clicks Group
- Turnover rose 7.4% to R19.5bn, led by pharmacy and distribution growth; retail faced some headwinds.CLS
Trading update22 Jan 2026 - EPS up 14.3%, turnover up 9.2%, and 2025 targets 40–50 new stores and pharmacies.CLS
H2 202418 Jan 2026 - HEPS up 13.2%, turnover up 6.2%, and 45–55 new stores planned amid strong cash flow.CLS
H1 202529 Nov 2025 - EPS up 14.1%, ROE at 49.2%, with strong cash flow and market share gains.CLS
H2 202523 Oct 2025